pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 10·1 min read
save

AI sepsis tools face timing challenges, says STAT AI Prognosis newsletter

Jun 10, 2026·read at STAT ↗Neutral

The latest STAT AI Prognosis newsletter notes that current sepsis detection algorithms sometimes require data from future time points, which is unrealistic.

The piece highlights how such quirks in medical data can mislead AI models and calls for more robust design that works with real‑time information.

The newsletter also mentions other AI topics, including AI‑generated clinical notes and recent biotech AI developments, while inviting readers to share feedback and subscribe.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Your sepsis algorithm shouldn’t require a time machine”

read at STAT ↗
469 words · retrieved Jun 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
PATH

related stories

  • May 15India’s pharma industry is going global. But can it catch up to China?BioPharma Dive
  • May 14With new data, Regenxbio to seek FDA approval of Duchenne gene therapyBioPharma Dive
  • May 14STAT+: Treatment for alcohol addiction is undergoing a seismic shift. Many say it’s overdueSTAT
  • May 13Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?STAT
  • May 13STAT+: AI medical devices’ dirty FDA secretSTAT